| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $71.6M | +11.5% |
| Cost of Revenue | $12.8M | +40.7% |
| Gross Profit | $58.8M | +6.6% |
| R&D Expense | $20.8M | +2.4% |
| SG&A Expense | $27.4M | -17.5% |
| Operating Income | -$42.5M | +24.8% |
| Interest Expense | $5.0M | -6.7% |
| Pre-tax Income | -$48.6M | +21.4% |
| Income Tax | $11K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.2M | -27.1% |
| Short-term Investments | $7.9M | -63.6% |
| Accounts Receivable | $9.1M | -22.9% |
| Inventory | $6.9M | -4.7% |
| Current Assets | $35.5M | -37.7% |
| Total Assets | $56.4M | -29.3% |
| Current Liabilities | $62.7M | +210.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.2M | +36.3% |
| Capital Expenditures | $1.0M | -89.0% |
| Investing Cash Flow | $12.5M | -66.7% |
| Financing Cash Flow | $14.9M | +325.8% |
| Free Cash Flow | -$32.2M | +44.6% |
| -79.6% |
| Net Income | -$48.6M | +21.4% |
| EPS (Basic) | -$1.74 | +27.2% |
| EPS (Diluted) | -$1.74 | +27.2% |
| Long-term Debt |
| $0 |
| -100.0% |
| Total Liabilities | $73.0M | -2.6% |
| Stockholders' Equity | -$16.6M | -470.1% |